Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Clinical trial NCT05713994 · RECRUITING

Trial details

NCT number: NCT05713994
Sponsor: Ze-yang Ding, MD
Status: RECRUITING
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Non-resectable

Start date: 2020-05-19
Primary completion: 2025-06-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.